title: Episodic hyperhidrosis as the only clinical manifestation of neuromyotonia.
authors.affiliation: Service of Neurology, Hospital Clinic, Barcelona, Spain. gomezchoco@hotmail.com
authors.forename: M J
authors.initials: MJ
authors.lastname: Gómez-Choco
authors.forename: J
authors.initials: J
authors.lastname: Valls-Solé
authors.forename: J M
authors.initials: JM
authors.lastname: Grau
authors.forename: F
authors.initials: F
authors.lastname: Graus
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004576:Electromyography; D006801:Humans; D006945:Hyperhidrosis / Q000209:etiology* / Q000503:physiopathology*; D020386:Isaacs Syndrome / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology*; D008297:Male; D018908:Muscle Weakness / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000503:physiopathology; D019653:Myeloablative Agonists / Q000627:therapeutic use; D010525:Peripheral Nerves / Q000503:physiopathology; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D013545:Sweat Glands / Q000294:innervation / Q000503:physiopathology; D017779:Sympathetic Fibers, Postganglionic / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D019653:Myeloablative Agonists; D003520:Cyclophosphamide; D011241:Prednisone